产品: | 磷酸化 SHIP1 (Tyr865) 抗体 |
货号: | AF7426 |
描述: | Rabbit polyclonal antibody to Phospho-SHIP1 (Tyr865) |
应用: | WB |
反应: | Human |
预测: | Pig, Bovine, Horse, Sheep, Rabbit, Dog, Xenopus |
分子量: | 100~160kD; 133kD(Calculated). |
蛋白号: | Q92835 |
RRID: | AB_2843866 |
产品描述
*The optimal dilutions should be determined by the end user.
*Tips:
WB: 适用于变性蛋白样本的免疫印迹检测. IHC: 适用于组织样本的石蜡(IHC-p)或冰冻(IHC-f)切片样本的免疫组化/荧光检测. IF/ICC: 适用于细胞样本的荧光检测. ELISA(peptide): 适用于抗原肽的ELISA检测.
引用格式: Affinity Biosciences Cat# AF7426, RRID:AB_2843866.
展开/折叠
Inositol polyphosphate 5 phosphatase of 145kDa; 4; 5-trisphosphate 5-phosphatase 1; hp51CN; Inositol polyphosphate 5 phosphatase 145kDa; Inositol polyphosphate 5 phosphatase; Inositol polyphosphate-5-phosphatase of 145 kDa; INPP5D; MGC104855; MGC142140; MGC142142; p150Ship; Phosphatidylinositol 3,4,5 trisphosphate 5 phosphatase 1; Phosphatidylinositol-3; SH2 containing inositol phosphatase isoform b; SH2 domain containing inositol 5' phosphatase 1; SH2 domain containing inositol phosphatase 1; SH2 domain-containing inositol phosphatase 1; SH2 domain-containing inositol-5''-phosphatase 1; SHIP-1; SHIP1; SHIP1_HUMAN; Signaling inositol polyphosphate 5 phosphatase SIP 145; SIP-145; SIP145;
抗原和靶标
Specifically expressed in immune and hematopoietic cells. Expressed in bone marrow and blood cells. Levels vary considerably within this compartment. Present in at least 74% of immature CD34+ cells, whereas within the more mature population of CD33+ cells, it is present in only 10% of cells. Present in the majority of T-cells, while it is present in a minority of B-cells (at protein level).
- Q92835 SHIP1_HUMAN:
- Protein BLAST With
- NCBI/
- ExPASy/
- Uniprot
MVPCWNHGNITRSKAEELLSRTGKDGSFLVRASESISRAYALCVLYRNCVYTYRILPNEDDKFTVQASEGVSMRFFTKLDQLIEFYKKENMGLVTHLQYPVPLEEEDTGDDPEEDTVESVVSPPELPPRNIPLTASSCEAKEVPFSNENPRATETSRPSLSETLFQRLQSMDTSGLPEEHLKAIQDYLSTQLAQDSEFVKTGSSSLPHLKKLTTLLCKELYGEVIRTLPSLESLQRLFDQQLSPGLRPRPQVPGEANPINMVSKLSQLTSLLSSIEDKVKALLHEGPESPHRPSLIPPVTFEVKAESLGIPQKMQLKVDVESGKLIIKKSKDGSEDKFYSHKKILQLIKSQKFLNKLVILVETEKEKILRKEYVFADSKKREGFCQLLQQMKNKHSEQPEPDMITIFIGTWNMGNAPPPKKITSWFLSKGQGKTRDDSADYIPHDIYVIGTQEDPLSEKEWLEILKHSLQEITSVTFKTVAIHTLWNIRIVVLAKPEHENRISHICTDNVKTGIANTLGNKGAVGVSFMFNGTSLGFVNSHLTSGSEKKLRRNQNYMNILRFLALGDKKLSPFNITHRFTHLFWFGDLNYRVDLPTWEAETIIQKIKQQQYADLLSHDQLLTERREQKVFLHFEEEEITFAPTYRFERLTRDKYAYTKQKATGMKYNLPSWCDRVLWKSYPLVHVVCQSYGSTSDIMTSDHSPVFATFEAGVTSQFVSKNGPGTVDSQGQIEFLRCYATLKTKSQTKFYLEFHSSCLESFVKSQEGENEEGSEGELVVKFGETLPKLKPIISDPEYLLDQHILISIKSSDSDESYGEGCIALRLEATETQLPIYTPLTHHGELTGHFQGEIKLQTSQGKTREKLYDFVKTERDESSGPKTLKSLTSHDPMKQWEVTSRAPPCSGSSITEIINPNYMGVGPFGPPMPLHVKQTLSPDQQPTAWSYDQPPKDSPLGPCRGESPPTPPGQPPISPKKFLPSTANRGLPPRTQESRPSDLGKNAGDTLPQEDLPLTKPEMFENPLYGSLSSFPKPAPRKDQESPKMPRKEPPPCPEPGILSPSIVLTKAQEADRGEGPGKQVPAPRLRSFTCSSSAEGRAAGGDKSQGKPKTPVSSQAPVPAKRPIKPSRSEINQQTPPTPTPRPPLPVKSPAVLHLQHSKGRDYRDNTELPHHGKHRPEEGPPGPLGRTAMQ
种属预测
score>80的预测可信度较高,可尝试用于WB检测。*预测模型主要基于免疫原序列比对,结果仅作参考,不作为质保凭据。
High(score>80) Medium(80>score>50) Low(score<50) No confidence
翻译修饰 - Q92835 作为底物
Site | PTM Type | Enzyme | Source |
---|---|---|---|
K14 | Ubiquitination | Uniprot | |
K24 | Ubiquitination | Uniprot | |
S27 | Phosphorylation | Uniprot | |
Y40 | Phosphorylation | Uniprot | |
Y46 | Phosphorylation | Uniprot | |
K78 | Ubiquitination | Uniprot | |
K141 | Ubiquitination | Uniprot | |
K182 | Ubiquitination | Uniprot | |
K200 | Ubiquitination | Uniprot | |
S205 | Phosphorylation | Uniprot | |
T213 | Phosphorylation | Uniprot | |
Y221 | Phosphorylation | Uniprot | |
S243 | Phosphorylation | Uniprot | |
S274 | Phosphorylation | Uniprot | |
S289 | Phosphorylation | Uniprot | |
S294 | Phosphorylation | Uniprot | |
Y339 | Phosphorylation | Uniprot | |
K365 | Ubiquitination | Uniprot | |
K371 | Acetylation | Uniprot | |
Y373 | Phosphorylation | Uniprot | |
T423 | Phosphorylation | Uniprot | |
Y556 | Phosphorylation | Uniprot | |
K607 | Ubiquitination | Uniprot | |
Y611 | Phosphorylation | Uniprot | |
Y644 | Phosphorylation | Uniprot | |
S699 | Phosphorylation | Uniprot | |
S744 | Phosphorylation | Uniprot | |
S754 | Phosphorylation | Uniprot | |
S755 | Phosphorylation | Uniprot | |
S772 | Phosphorylation | Uniprot | |
K779 | Ubiquitination | Uniprot | |
K786 | Ubiquitination | Uniprot | |
Y796 | Phosphorylation | Uniprot | |
Y834 | Phosphorylation | Uniprot | |
T835 | Phosphorylation | Uniprot | |
K859 | Ubiquitination | Uniprot | |
K863 | Ubiquitination | Uniprot | |
Y865 | Phosphorylation | Uniprot | |
K869 | Ubiquitination | Uniprot | |
K879 | Ubiquitination | Uniprot | |
T880 | Phosphorylation | Uniprot | |
K882 | Ubiquitination | Uniprot | |
S886 | Phosphorylation | Uniprot | |
K891 | Ubiquitination | Uniprot | |
T908 | Phosphorylation | Uniprot | |
Y915 | Phosphorylation | Uniprot | |
S934 | Phosphorylation | Uniprot | |
Y944 | Phosphorylation | Uniprot | |
S951 | Phosphorylation | Uniprot | |
S960 | Phosphorylation | Uniprot | |
T963 | Phosphorylation | Uniprot | |
S971 | Phosphorylation | Uniprot | |
K974 | Ubiquitination | Uniprot | |
S978 | Phosphorylation | Uniprot | |
T979 | Phosphorylation | Uniprot | |
T1003 | Phosphorylation | Uniprot | |
Y1022 | Phosphorylation | Uniprot | |
S1024 | Phosphorylation | Uniprot | |
S1026 | Phosphorylation | Uniprot | |
S1027 | Phosphorylation | Uniprot | |
S1039 | Phosphorylation | Uniprot | |
K1045 | Ubiquitination | Uniprot | |
S1057 | Phosphorylation | Uniprot | |
K1076 | Ubiquitination | Uniprot | |
S1085 | Phosphorylation | Uniprot | |
K1107 | Ubiquitination | Uniprot | |
T1108 | Phosphorylation | Uniprot | |
K1119 | Ubiquitination | Uniprot | |
K1123 | Ubiquitination | Uniprot | |
T1133 | Phosphorylation | Uniprot | |
T1136 | Phosphorylation | Uniprot | |
R1140 | Methylation | Uniprot | |
S1147 | Phosphorylation | Uniprot | |
S1156 | Phosphorylation | Uniprot | |
K1157 | Ubiquitination | Uniprot | |
Y1161 | Phosphorylation | Uniprot | |
K1172 | Ubiquitination | Uniprot |
研究背景
Phosphatidylinositol (PtdIns) phosphatase that specifically hydrolyzes the 5-phosphate of phosphatidylinositol-3,4,5-trisphosphate (PtdIns(3,4,5)P3) to produce PtdIns(3,4)P2, thereby negatively regulating the PI3K (phosphoinositide 3-kinase) pathways. Able also to hydrolyzes the 5-phosphate of phosphatidylinositol-4,5-bisphosphate (PtdIns(4,5)P3) and inositol 1,3,4,5-tetrakisphosphate. Acts as a negative regulator of B-cell antigen receptor signaling. Mediates signaling from the FC-gamma-RIIB receptor (FCGR2B), playing a central role in terminating signal transduction from activating immune/hematopoietic cell receptor systems. Acts as a negative regulator of myeloid cell proliferation/survival and chemotaxis, mast cell degranulation, immune cells homeostasis, integrin alpha-IIb/beta-3 signaling in platelets and JNK signaling in B-cells. Regulates proliferation of osteoclast precursors, macrophage programming, phagocytosis and activation and is required for endotoxin tolerance. Involved in the control of cell-cell junctions, CD32a signaling in neutrophils and modulation of EGF-induced phospholipase C activity. Key regulator of neutrophil migration, by governing the formation of the leading edge and polarization required for chemotaxis. Modulates FCGR3/CD16-mediated cytotoxicity in NK cells. Mediates the activin/TGF-beta-induced apoptosis through its Smad-dependent expression.
Tyrosine phosphorylated by the members of the SRC family after exposure to a diverse array of extracellular stimuli such as cytokines, growth factors, antibodies, chemokines, integrin ligands and hypertonic and oxidative stress. Phosphorylated upon IgG receptor FCGR2B-binding.
Cytoplasm. Cell membrane>Peripheral membrane protein. Membrane raft. Cytoplasm>Cytoskeleton. Membrane>Peripheral membrane protein.
Note: Translocates to the plasma membrane when activated, translocation is probably due to different mechanisms depending on the stimulus and cell type. Translocates from the cytoplasm to membrane ruffles in a FCGR3/CD16-dependent manner. Colocalizes with FC-gamma-RIIB receptor (FCGR2B) or FCGR3/CD16 at membrane ruffles. Tyrosine phosphorylation may also participate in membrane localization.
Specifically expressed in immune and hematopoietic cells. Expressed in bone marrow and blood cells. Levels vary considerably within this compartment. Present in at least 74% of immature CD34+ cells, whereas within the more mature population of CD33+ cells, it is present in only 10% of cells. Present in the majority of T-cells, while it is present in a minority of B-cells (at protein level).
Interacts with tyrosine phosphorylated form of SHC1. Interacts with tyrosine phosphorylated form of DOK1. Interacts with tyrosine phosphorylated form of DOK3 (By similarity). Interacts with tyrosine phosphorylated form of SLAMF1/CD150. Interacts with PTPN11 in response to IL-3 (By similarity). Interacts with receptor EPOR (By similarity). Interacts with receptors MS4A2/FCER1B and FCER1G (By similarity). Interacts with receptors FCGR2B and FCGR3 (By similarity). Interacts with receptor FCGR2A, leading to regulate gene expression during the phagocytic process (By similarity). Interacts with GRB2. Interacts with PLCG1 (By similarity). Interacts with tyrosine kinases SRC and TEC (By similarity). Interacts with c-Met/MET (By similarity). Interacts with MILR1 (tyrosine-phosphorylated) (By similarity). Can weakly interact (via NPXY motif 2) with DAB2 (via PID domain); the interaction is impaired by tyrosine phosphorylation of the NPXY motif (By similarity). Interacts with FCRL3 and FCRL6 (tyrosine phosphorylated form).
The SH2 domain interacts with tyrosine phosphorylated forms of proteins such as SHC1 or PTPN11/SHP-2. It competes with that of GRB2 for binding to phosphorylated SHC1 to inhibit the Ras pathway. It is also required for tyrosine phosphorylation (By similarity).
The NPXY sequence motif found in many tyrosine-phosphorylated proteins is required for the specific binding of the PID domain.
Belongs to the inositol 1,4,5-trisphosphate 5-phosphatase family.
研究领域
· Environmental Information Processing > Signal transduction > Phosphatidylinositol signaling system.
· Metabolism > Carbohydrate metabolism > Inositol phosphate metabolism.
· Organismal Systems > Immune system > B cell receptor signaling pathway. (View pathway)
· Organismal Systems > Immune system > Fc epsilon RI signaling pathway. (View pathway)
· Organismal Systems > Immune system > Fc gamma R-mediated phagocytosis. (View pathway)
限制条款
产品的规格、报价、验证数据请以官网为准,官网链接:www.affbiotech.com | www.affbiotech.cn(简体中文)| www.affbiotech.jp(日本語)产品的数据信息为Affinity所有,未经授权不得收集Affinity官网数据或资料用于商业用途,对抄袭产品数据的行为我们将保留诉诸法律的权利。
产品相关数据会因产品批次、产品检测情况随时调整,如您已订购该产品,请以订购时随货说明书为准,否则请以官网内容为准,官网内容有改动时恕不另行通知。
Affinity保证所销售产品均经过严格质量检测。如您购买的商品在规定时间内出现问题需要售后时,请您在Affinity官方渠道提交售后申请。产品仅供科学研究使用。不用于诊断和治疗。
产品未经授权不得转售。
Affinity Biosciences将不会对在使用我们的产品时可能发生的专利侵权或其他侵权行为负责。Affinity Biosciences, Affinity Biosciences标志和所有其他商标所有权归Affinity Biosciences LTD.